New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-α-methylhistamine1 containing a heteroarylphenyl partial structure

Archiv der Pharmazie

Volumn 329, Issue 4, 1996, Pages 209-215

  Krause, Michael ^a   Rouleau, Agnès ^b   Stark, Holger ^a   Luger, Peter ^a   Garbarg, Monique ^b   Schwartz, Jean Charles ^b   Schunack, Walter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CENTRE PAUL BROCA   (France)

Author keywords

Agonist; Azomethine; Histamine H3 receptor; Prodrug

Indexed keywords

4 FLUORO 2 [4N [1 (1H IMIDAZOL 4 YL) 2 PROPYL]IMINO (1H PYRROL 2 YL)METHYL]PHENOL; ALPHA METHYLHISTAMINE; HISTAMINE H3 RECEPTOR; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROLYSIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; X RAY ANALYSIS;

ANIMALS; HETEROCYCLIC COMPOUNDS; HISTAMINE; HISTAMINE AGONISTS; IMINES; MALE; METHYLHISTAMINES; MICE; MOLECULAR STRUCTURE; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029899088     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19963290407     Document Type: Article

References (31)

1. J.-M. Arrang, M. Garbarg, J.-C Schwartz,Nature (London) 1983, 302, 832-837.
2. J.-M. Arrang, M. Garbarg, J.-C. Schwartz, Neuroscience 1985, 15, 553-562.
3. J.-M. Arrang, M. Garbarg, J.-C. Schwartz, Neuroscience 1987, 23, 149-157.
4. J. Clapham, G.J. Kilpatrick, Br. J. Pharmacol. 1992, 107, 919-923.
5. E. Schlicker, K. Fink, M Detzner, M. Göthert, J. Neural. Transm. [GenSect] 1993, 93, 1-10.
6. K. Fink, E. Schlicker, M. Göthert. Adv. Biosci. 1991, 82, 125-126.
7. E. Schlicker, R. Betz, M. Göthert, Naunyn-Schmiedebergs Arch. Pharmacol. 1988, 337, 588-590.
8. J.-M. Arrang, B. Devaux, J.-P. Chodkiewicz, J.-C. Schwartz, J. Neurochem. 1988, 51, 105-108.
9. H. Pollard, J. Moreau, J.-M. Arrang, J.-C. Schwartz, Neuroscience 1993, 52, 169-189.
10. [101 X. Ligneau, M. Garbarg, M.L. Vizuette, J. Diaz, K. Purand, H. Stark, W. Schunack, J.-C. Schwartz, J. Pharmacol. Exp. Ther. 1994, 271, 452-459.
11. G. Bertaccini, G. Corruzzi, in The Histamine Receptor, Receptor Biochemistry and Methodology (Eds.: J.-C. Schwartz, H. L. Haas), Wiley-Liss, Inc., New York, 1992, chapter 10, pp 193-230.
12. P.J. Barnes, in The Histamine Receptor, Receptor Biochemistry and Methodology (Eds.: J.-C. Schwartz, H.L. Haas), Wiley-Liss, Inc., New York, 1992, chapter 12, pp 253-270.
13. G. Gerhard, W. Schunack, Arch. Pharm. (Weinheim) 1980, 313, 709-714.
14. J.-M. Arrang, M. Garbarg, J.-C. Lancelot, J.-M. Lecomte, H. Pollard, M. Robba, W. Schunack, J.-C. Schwartz, Nature (London) 1987, 327, 117-123.
15. R. Lipp, J.-M. Arrang, M. Garbarg, P. Luger, J.-C. Schwartz, W. Schunack, J. Med. Chem. 1992, 35, 4434-4441.
16. S. Yamazaki, E. Sakurai, N. Hikichi, N Sakai, K. Maeyama, T. Watanabe, J. Pharm. Pharmacol. 1994, 46, 371-374.
17. L.B. Hough, J.K. Khandelwal, T.W. Mittag, Agents Actions 1981, 11, 425-428.
18. A. Rouleau, M. Garbarg, X. Ligneau, C. Mantion, P Lavie, C. Advenier, J.-M. Lecomte, M. Krause, H. Stark, W. Schunack, J.-C. Schwartz, J. Pharmacol. Exp. Ther , submitted.
19. M. Garbarg, J.-M. Arrang, W. Schunack, R. Lipp, H. Stark, J.-M. Lecomte, J.-C. Schwartz, PCT Int. Appl. WO 91/17 146. 1991 [Chem. Abstr. 1992, 116, P194311]
20. W. Schunack, H. Stark, Eur. J. Drug Metab. Pharmacokinet. 1994, 3, 173-178.
21. M. Krause, A. Rouleau, H. Stark, P. Luger, R. Lipp, M. Garbarg, J.-C. Schwartz, W. Schunack, J. Med. Chem. 1995, 38, 4070-4079.
22. J.-P. Kaplan, B.M. Raizon, M. Desarmien, P. Feltz, P.M. Headly, P. Worms, K.G. Lloyd, G. Bartholini, J. Med. Chem. 1980, 23, 702-704.
23. J. Jílek, J Pomykácek, H. Frycová, Z. Polívka, Cesk. Farm. 1990, 39, 249-253.
24. J.-M. Lecomte, et al. Unpublished Results.
25. A. Einhorn, F. Hollandt, Ann. Chem. 1898, 301, 95-101.
26. K. Fries, G. Finck, Ber. Dtsch. Chem. Ges. 1908, 41, 4271.
27. E. Keller, SCHAKAL86, Program for the Graphic Representation of Molecular and Cristallographic Models; University of Freiburg: Germany, 1986.
28. G.M. Sheldrick, In Crystallographic Computing 3 (Eds.: G. M. Sheldrick, C. Krüger, R. Goddard), Oxford University Press, Oxford, 1985, pp 175-198.
29. J.M. Stewart, H.D. Flack, S.R. Hall, Eds. XTAL Program System 3.2, Users Manual; University of Western Australia, Geneva and Maryland, 1992.
30. M. Garbarg, H. Pollard, M. D. Trung Tuong, J.-C Schwartz, C. Gros, J. Neurochem. 1989, 53, 1724-1730.
31. J.W. Black, C.R. Ganellin, Experientia 1974, 30, 111-113.